International law firm McDermott Will & Emery today announced that Michael Siekman and Jenny Chen have joined the Intellectual Property (IP) practice as partners based in the Boston office. The duo builds upon Boston’s active and diverse IP practice and will complement the Firm’s robust legal service offering to the life sciences and health industries. The pair join from Polsinelli in Boston.
“We are laser focused on smart expansion, and virtually every McDermott practice group and geography is focused on legal representation for the life sciences sector,” said Michael Poulos, head of strategy at the Firm. “Our new partners reflect our continuing strategic commitment to growing the preeminent life science practice in our industry.”
“The last few years have shown an increasing need for breakthrough innovations in the life sciences market. Patent protection is essential for bringing necessary technology to market, and Michael and Jenny truly understand what it takes to be a fearless client advocate during every stage of the IP lifecycle,” Bill Gaede, leader of the Firm’s Global Intellectual Property practice, said. “Michael’s and Jenny’s addition in Boston bolsters our IP capabilities in this leading region for life sciences innovators and research institutions as well as across our international platform.”
“This IP team is a natural part of our planned Boston expansion given the significance of the life sciences industry to our region,” added Tony Bongiorno, litigation partner and Boston office managing partner. “We look forward to collaborating with Michael and Jenny on exciting opportunities across all of our practices in Boston.”
Michael focuses his practice on a broad range of intellectual property matters, including architecting patent prosecution strategies, life sciences partnering and transactions, licensing, post-grant proceedings and litigation. Leveraging over 25 years of experience, Michael has built in-depth patent portfolios, advising clients in the biotechnology and pharmaceutical industries.
“We are thrilled to join McDermott as we share the Firm’s commitment to partnering with clients and protecting and maximizing their investment in critical life sciences technologies,” Michael added. “The Firm’s leading position in the life sciences and healthcare industries provides an unmatched platform for our work.”
Jenny counsels both US and international clients in a variety of patent-related matters in the biotech and life sciences space, including prosecution, due diligence and post-grant proceedings. Her practice focuses on matters including cell and gene therapies, antibodies, diagnosis and pharmaceutical formulations. She is particularly experienced in strategic counseling on life cycle management of both biological and small molecule products.
Michael received his BS at Bates College and his JD at Boston University School of Law. Jenny received her BS from Fudan University, her PhD in Pharmacology from Baylor College of Medicine and her JD from Northeastern University School of Law.
Source: www.mwe.com
